Article info
Original research
Olanzapine cost-effectiveness in vomiting and nausea from highly emetogenic chemotherapy in children and adolescents
- Correspondence to Dr Sameer Bakhshi, Medical Oncology, All India Institute of Medical Sciences, New Delhi 110029, Delhi, India; sambakh{at}hotmail.com
Citation
Olanzapine cost-effectiveness in vomiting and nausea from highly emetogenic chemotherapy in children and adolescents
Publication history
- Received November 3, 2022
- Accepted February 8, 2023
- First published February 22, 2023.
Online issue publication
January 08, 2024
Article Versions
- Previous version (22 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.